In conclusion, although no significant associations of NAT2 genetic variations with the overall risk of colorectal adenoma were revealed, statistically significant findings were noted in individuals with a history of smoking, suggesting that NAT2 genetic variations may modify the colorectal adenoma risk of smokers. Here, NAT2 is linked to colorectal adenoma.